Biography
Felix Masiye, MSc, PhD, is the Dean of the School of Humanities and Social Sciences at the University of Zambia and an Affiliate Assistant Professor at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. He is the country principal investigator for the multicountry Gavi Full Country Evaluations (FCE) work in Zambia, led by IHME. The FCE aims to assess the contribution of Gavi support to immunization program performance in Zambia. Previously, Dr. Masiye was a co-investigator on the Malaria Control Policy Assessment project, a collaborative project between IHME and the University of Zambia. The study evaluated the impact of malaria control and other health interventions on childhood mortality in Zambia. He also collaborated on the IHME project Access, Bottlenecks, Costs, and Equity (ABCE) in Zambia.
In his role as affiliate faculty, Dr. Masiye supervises students’ Master of Public Health theses, serves as a supervisor for students conducting their practicums in Zambia, participates in courses by giving lectures in person when in Seattle or remotely, and serves as a resource for students working on data from Zambia.
Dr. Masiye has extensive knowledge of health systems in sub-Saharan Africa. He sits on technical committees in health care financing and monitoring and evaluation at the Ministry of Health in Zambia. He has published a number of papers in health financing, economic evaluation, equity in health, and health system performance assessment.
Dr. Masiye earned his BA in Economics at the University of Zambia, and his MS in Economics and PhD in Economics from the University of Cape Town. He was a postdoctoral fellow at the Harvard University Initiative for Global Health from 2006 to 2008.
IHME was established at the University of Washington in Seattle in 2007. Its mission is to deliver to the world timely, relevant, and scientifically valid evidence to improve health policy and practice.
GBD 2017 Population and Fertility Collaborators. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1995-2051. doi: http://dx.doi.org/10.1016/S0140-6736(18)32278-5.
GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1684-735. doi: http://dx.doi.org/10.1016/S0140-6736(18)31891-9.
Global Burden of Disease Health Financing Collaborator Network. Evolution and patterns of global health financing 1995–2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries. The Lancet. 19 April 2017. http://dx.doi.org/10.1016/S0140-6736(17)30874-7
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1659–1724.
GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1603–1658.
GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1775–1812.
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1459–1544.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1545–1602.
GBD 2015 Child Mortality Collaborators. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1725–1774.
Lim SS, Allen K, Bhutta ZA, et al. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. The Lancet. 2016 Sep 21. doi: 10.1016/S0140-6736(16)31467-2.
Di Giorgio L, Moses MW, Fullman N, et al. The potential to expand antiretroviral therapy by improving health facility efficiency: evidence from Kenya, Uganda, and Zambia. BMC Medicine. 2016 20 July. doi: 10.1186/s12916-016-0653-z.
Ng M, Colson KE, Fullman N, Dwyer-Lindgren L, Achoki T, Schneider MT, Mulenga P, Hangoma P, Masiye F, Gakidou E. Assessing the contribution of malaria vector control and other maternal and child health interventions in reducing all-cause under-5 mortality in Zambia. American Journal of Tropical Medicine and Hygiene. 2016 Feb 15. doi: 10.4269/ajtmh.15-0315.
Dansereau E, Masiye F, Gakidou E, Masters SH, Burstein R, Kumar S. Patient satisfaction and perceived quality of care: evidence from a cross-sectional national exit survey of HIV and non-HIV service users in Zambia. BMJ Open. 2015 Dec 30. doi:10.1136/bmjopen-2015-009700.
Forouzanfar MH, Alexander L, Anderson HR, et al. Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015 Sep 11. doi: 10.1016/S0140-6736(15)61455-6.
Colson KE, Dwyer-Lindgren L, Achoki T, Fullman N, Schneider M, Mulenga P, Hangoma P, Ng M, Masiye F, Gakidou E. Benchmarking health system performance across districts in Zambia: a systematic analysis of levels and trends in key maternal and child health interventions from 1990 to 2010. BMC Medicine. 2015 April 2. doi: 10.1186/s12916-0150308-5.
Duber HC, Dansereau E, Masters SH, Achan J, Burstein R, DeCenso B, Gasasira A, Ikilezi G, Kisia C, Masiye F, Njuguna P, Odeny T, Okiro E, Roberts DA, Gakidou E. Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia. PLOS One. 2015 March 25. doi: 10.1371/journal.pone.0120350.
Naghavi M, Wang H, Lozano R, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014 Dec 17. doi: 10.1016/S0140-6736(14)61682-2.
Dwyer-Lindgren L, Kakungu F, Hangoma P, Ng M, Wang H, Flaxman AD, Masiye F, Gakidou E. Estimation of district-level under-5 mortality in Zambia using birth history data, 1980–2010. Spatial and Spatio-temporal Epidemiology. 2014 Oct;11: 89-107. doi: 10.1016/j.sste.2014.09.002.
Lim SS, Fullman N, Stokes A, Ravishankar N, Masiye F, Murray CJL, Gakidou E. Net benefits: a multicountry analysis of observational data examining associations between insecticide-treated mosquito nets and health outcomes. PLoS Medicine. September 2011; 8(9): e1001.